0.830
0.02 (2.47%)
| 前收盘价格 | 0.810 |
| 收盘价格 | 0.845 |
| 成交量 | 15,204 |
| 平均成交量 (3个月) | 27,170 |
| 市值 | 126,473,736 |
| 预期市盈率 (P/E Forward) | 34.36 |
| 价格/销量 (P/S) | 0.720 |
| 股市价格/股市净资产 (P/B) | 1.09 |
| 52周波幅 | |
| 利润日期 | 25 Aug 2021 |
| 营业毛利率 | -17.84% |
| 营业利益率 (TTM) | 1.18% |
| 稀释每股收益 (EPS TTM) | -0.190 |
| 季度收入增长率 (YOY) | 6.00% |
| 总债务/股东权益 (D/E MRQ) | 52.94% |
| 流动比率 (MRQ) | 0.940 |
| 营业现金流 (OCF TTM) | 11.95 M |
| 杠杆自由现金流 (LFCF TTM) | 11.50 M |
| 资产报酬率 (ROA TTM) | 0.81% |
| 股东权益报酬率 (ROE TTM) | -24.66% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (AU) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 混合的 | |
| 股票 | TRAJAN GRO FPO [TRJ] | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -2.0 |
| 平均 | -1.00 |
|
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA). |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 58.24% |
| 机构持股比例 | 25.23% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合